Tonic adenosine A1 and A2A receptor activation is required for the excitatory action of VIP on synaptic transmission in the CA1 area of the hippocampus

Neuropharmacology

Volumn 52, Issue 2, 2007, Pages 313-320

  Cunha Reis, D ^a   Fontinha, B M ^a   Ribeiro, J A ^a   Sebastiao A M ^a  

^a INSTITUTO DE MEDICINA MOLECULAR JOÃO LOBO ANTUNES   (Portugal)

Author keywords

A1 adenosine receptors; A2A adenosine receptors; fEPSPs; Hippocampus; PSs; VIP

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 4 [2 [7 AMINO 2 (2 FURYL) 1,2,4 TRIAZOLO[2,3 A][1,3,5]TRIAZIN 5 YLAMINO]ETHYL]PHENOL; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE; ADENOSINE A1 RECEPTOR; ADENOSINE A2 RECEPTOR; ADENOSINE DEAMINASE; CYCLOHEXYLADENOSINE; NEUROTRANSMITTER; VASOACTIVE INTESTINAL POLYPEPTIDE; 1,3-DIPROPYL-8-CYCLOPENTYLXANTHINE; 5 AMINO 2 (2 FURYL) 7 (2 PHENYLETHYL)PYRAZOLO[4,3 E][1,2,4]TRIAZOLO[1,5 C]PYRIMIDINE; ADENOSINE A2A RECEPTOR; DRUG DERIVATIVE; N(6) CYCLOHEXYLADENOSINE; N(6)-CYCLOHEXYLADENOSINE; NEUROPROTECTIVE AGENT; PYRIMIDINE DERIVATIVE; TRIAZINE DERIVATIVE; TRIAZOLE DERIVATIVE; UNCLASSIFIED DRUG; XANTHINE DERIVATIVE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DENDRITE; EXCITATORY POSTSYNAPTIC POTENTIAL; FACILITATION; HIPPOCAMPUS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PYRAMIDAL NERVE CELL; RAT; RECEPTOR BINDING; RECEPTOR SENSITIVITY; SYNAPTIC INHIBITION; SYNAPTIC TRANSMISSION; ANALYSIS OF VARIANCE; ANIMAL; CELL MEMBRANE POTENTIAL; DRUG EFFECT; DRUG INTERACTION; ELECTROSTIMULATION; IN VITRO STUDY; METABOLISM; METHODOLOGY; PATCH CLAMP; RADIATION EXPOSURE; WISTAR RAT;

ADENOSINE; ADENOSINE DEAMINASE; ANALYSIS OF VARIANCE; ANIMALS; DRUG INTERACTIONS; ELECTRIC STIMULATION; EXCITATORY POSTSYNAPTIC POTENTIALS; HIPPOCAMPUS; MALE; MEMBRANE POTENTIALS; NEUROPROTECTIVE AGENTS; PATCH-CLAMP TECHNIQUES; PYRIMIDINES; RATS; RATS, WISTAR; RECEPTOR, ADENOSINE A1; RECEPTOR, ADENOSINE A2A; SYNAPTIC TRANSMISSION; TRIAZINES; TRIAZOLES; VASOACTIVE INTESTINAL PEPTIDE; XANTHINES;

EID: 33846271369     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2006.08.003     Document Type: Article

References (32)

1. Acsády L., Arabadzisz D., and Freund T.F. Correlated morphological and neurochemical features identify different subsets of vasoactive intestinal polypeptide-immunoreactive interneurons in the rat hippocampus. Neuroscience 73 (1996) 299-315
2. Anderson W.W., and Collingridge G.L. The LTP Program: a data acquisition program for on-line analysis of long-term potentiation and other synaptic events. Journal of Neuroscience Methods 108 (2001) 71-83
3. Boison D. Adenosine and epilepsy: from therapeutic rationale to new therapeutic strategies. Neuroscientist 11 (2005) 25-36
4. Catania M.V., Sortino M.A., Rampello O.L., Canonico P.L., and Nicoletti F. Adenosine deaminase increases release of excitatory amino acids through a mechanism independent of adenosine depletion. Neuropharmacology 30 (1991) 153-159
5. Ciranna L., and Cavallaro S. Opposing effects by pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal peptide on hippocampal synaptic transmission. Experimental Neurology 184 (2003) 778-784
6. 3H]-ACh release from rat motor nerve endings. British Journal of Pharmacology 111 (1994) 582-588
7. 3H]-ACh release from the rat motor nerve terminals. Neuroscience Letters 309 (2001) 101-104
8. 3H]-GABA release from rat hippocampal nerve terminals. Neuropharmacology 39 (2000) 1156-1167
9. 2A receptors. Naunyn-Schmiedeberg's Archives of Pharmacology 353 (1996) 261-271
10. Cunha-Reis D., Sebastião A.M., Wirkner K., Illes P., and Ribeiro J.A. VIP enhances both pre- and post-synaptic GABAergic transmission to hippocampal interneurones leading to increased excitatory synaptic transmission to CA1 pyramidal cells. British Journal of Pharmacology 143 (2004) 733-744
11. 2 receptors. Brain Research 1049 (2005) 52-60
12. 2 receptor activation mediates VIP enhancement of population spikes in the CA1 area of the hippocampus. Annals of the New York Academy of Sciences 1070, 210-214.
13. De Lanerolle N.S., Gunel M., Sundaresan S., Shen M.Y., Brines M.L., and Spencer D.D. Vasoactive intestinal polypeptide and its receptor changes in human temporal lobe epilepsy. Brain Research 686 (1995) 182-193
14. Dunwiddie T.V., and Masino S.A. The role and regulation of adenosine in the central nervous system. Annual Review of Neuroscience 24 (2001) 31-55
15. Haas H.L., and Gähwiller B.H. Vasoactive intestinal polypeptide modulates neuronal excitability in hippocampal slices of the rat. Neuroscience 47 (1992) 273-277
16. Haas H.L., and Greene R.W. Adenosine enhances afterhyperpolarization and accommodation in hippocampal pyramidal cells. Pflügers Archives 402 (1984) 244-247
17. Haskó G., Sitkovsky M.V., and Szabó C. Immunomodulatory and neuroprotective effects of inosine. Trends in Neuroscience 25 (2004) 152-157
18. Sahp, by the neuropeptides CRF, VIP, and CGRP in hippocampal pyramidal neurons. Journal of Neurophysiology 83 (2000) 2071-2079
19. King Jr. J.T., and LaMotte C.C. VIP-, SS-, and GABA-like immunoreactivity in the mid-hippocampal region of El (epileptic) and C57BL/6 mice. Brain Research 475 (1988) 192-197
20. Lambert N.A., and Teyler T.J. Adenosine depresses excitatory but not fast inhibitory synaptic transmission in area CA1 of the rat hippocampus. Neuroscience Letters 122 (1991) 50-52
21. 2 receptor mediation of pre- and postsynaptic excitatory effects of adenosine in rat hippocampus in vitro. European Journal of Pharmacology 347 (1998) 173-182
22. Li H., and Henry J.L. Adenosine action on interneurons and synaptic transmission onto intereneurons in rat hippocampus in vitro. European Journal of Pharmacology 407 (2000) 237-244
23. 1 receptor responses. European Journal of Pharmacology 383 (1999) 395-398
24. 1 receptor inhibition. Neuroscience 112 (2002) 319-329
25. Marksteiner J., Sperk G., and Maas D. Differential increases in brain levels of neuropeptide Y and vasoactive intestinal polypeptide after kainic acid-induced seizures in the rat. Naunyn Schmiedebergs Arch Pharmacology 339 (1989) 173-177
26. 1 receptor-specific monoclonal antibody. Journal of Comparative Neurology 411 (1999) 301-316
27. Ribeiro J.A., Sebastião A.M., and de Mendonça A. Adenosine receptors in the nervous system: pathophysiological implications. Progress in Neurobiology 68 (2003) 377-392
28. Rosenberg P.A., and Li Y. Vasoactive intestinal peptide regulates extracellular adenosine levels in rat cortical cultures. Neuroscience Letter 200 (1995) 93-96
29. Sebastião A.M., and Ribeiro J.A. Fine-tuning neuromodulation by adenosine. Trends in Pharmacolological Sciences 21 (2000) 341-346
30. 1 receptors prevents, a facilitatory action of calcitonin gene-related peptide in the rat hippocampus. British Journal of Pharmacology 129 (2000) 374-380
31. Wright R.A., and Schoepp D.D. Differentiation of group 2 and group 3 metabotropic glutamate receptor cAMP responses in the rat hippocampus. European Journal of Pharmacology 297 (1996) 275-282
32. Yoon K.-W., and Rothman S.M. Adenosine inhibits excitatory but not inhibitory synaptic transmission in the hippocampus. Journal of Neuroscience 11 (1991) 1375-1380